Acl Reconstruction denied as experimental or investigational by Aetna?

Aetna's specific coverage criteria for acl reconstruction are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna May Deny ACL Reconstruction as Experimental

Standard ACL reconstruction is a well-established, widely covered surgical procedure. An "experimental" or "investigational" denial for ACL reconstruction almost always means that the specific technique or graft type being requested — rather than the procedure category itself — falls outside what Aetna considers proven. Examples include newer biological augmentation techniques, synthetic graft materials, internal brace augmentation, or a procedure being performed in combination with a study protocol. Aetna's Clinical Policy Bulletins define what constitutes investigational, and denials typically cite that the evidence base for the specific approach does not meet Aetna's evidence-review standard.

## Your Right to Appeal

ACA §2719 and its implementing regulations require that plans base experimental/investigational denials on recognized clinical evidence, and that patients have access to independent external review. External review for experimental denials is specifically protected under federal law and must be conducted by a clinical reviewer with relevant expertise. External review must generally be requested within four months of the final internal denial. An expedited appeal is available when delay would seriously jeopardize health.

## Building Your Appeal

1. Identify the specific technique at issue — obtain the denial letter and Aetna's applicable Clinical Policy Bulletin. Identify precisely which aspect of the planned procedure Aetna labeled investigational (e.g., a specific graft type, augmentation method, or concomitant biological treatment). 2. Evidence of clinical acceptance — work with the treating orthopedic surgeon to gather peer-reviewed published literature, applicable guideline statements from the relevant orthopedic specialty society (such as the American Academy of Orthopaedic Surgeons), and any FDA clearance or approval documentation for devices or materials involved. The external reviewer will assess whether the evidence base meets coverage standards. 3. Distinguish from study enrollment — if the patient is not enrolled in a clinical trial and the procedure is being performed as standard clinical care, document this explicitly. Experimental denials sometimes arise from superficial similarity to a study protocol rather than actual investigational use. 4. Prescriber letter — the surgeon should write a letter explaining the clinical rationale for the specific technique, citing published evidence and guideline support, and confirming this is standard-of-care treatment for this patient's anatomy and activity needs.

## Criteria-Mapping Structure

Copy the exact "investigational" criteria from Aetna's Clinical Policy Bulletin. Create a two-column table: left column lists each criterion; right column presents the published evidence and chart documentation that addresses it. Attach peer-reviewed references as numbered exhibits.